No products in the cart.
60 Capsules Small
500mg /capsule
Price : 196 $ USD
Another size
45 Capsules Big
775mg / capsule
Price : 220 $ USD
Components :
Taraxaum officinalis / leaves
Centaurium officinalis / buds
Trigonella foenum / seeds
Agrapyron repens / roots
KL GLIMA (1-17-20) :
Product based on natural medicinal plants, belongs of the tired drug generation, it is without side effects, adjuvant in the treatment : diabetes, its complications and repercussions.
Indications :
– Type II diabetes.
– Insulin disorders.
– Insulin resistance.
– High level of glycated hemoglobin.
– Diabetic retinopathy, diabetic foot.
– Arterial hypertension.
– Dyslipidemia.
– Obesity caused by the consumption of sweets.
– Repercussions of diabetes on sexuality.
K L GLIMA 1.17.20
– Promotes good blood circulation and reduces insulin resistance.
– Improves cell metabolism.
– Modulates the secretion of insulin by the beta cells of the pancreas to maintain the balance of blood sugar levels.
– Inhibits alpha glucosidase at the intestinal level to slow down the absorption of carbohydrates.
– Prevents diabetic ketoacidosis.
– Regulates the expression of the glycogenic response to insulin.
– Induces glycosuria by modulation of sodium-glucose cotransporter 2
(SGTL2) for the balance of the level of glycated hemoglobin.
– Prevents insulin shock (known in diabetics) by regulating liver function.
– Modulates glucagon synthesis by pancratic alpha cells.
(gluconeogenesis) for glycemic balance.
– Prevents cardiovascular and pulmonary complications in diabetics as well as diabetic neuropathy.
– Protects against arterial stenosis, prevents the formation of aheroma plaques.
– Contributes to the modulation of insulin which is a factor of arterial hypertension in diabetics and prevents renal complications.
– Helps fight stress that often raises blood sugar.
– Protects against the repercussions of diabetes on sexuality, namely reduced libido, yeast infections and vaginal dryness in women, prostatitis and erectile dysfunction in men.
Reviews
There are no reviews yet.